Not surprisingly, the gene expression values that drove this classification were highly divergent from each other, such as CD3D for T-ALL and CD19 and EBF1 (early B-cell factor 1) for pre-B-ALL. This evidence concerns the gene EBF1 and acute lymphoblastic leukemia.